Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion type Assertion NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_head.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion description "[Taken together, our results indicate that CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions and suggest CITED4 hypermethylation as a novel prognostic marker in oligodendroglioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_provenance.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion evidence source_evidence_literature NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_provenance.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion SIO_000772 17311001 NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_provenance.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion wasDerivedFrom befree-2016 NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_provenance.
- NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_assertion wasGeneratedBy ECO_0000203 NP594853.RALCdue7wAWiaAxIL0e6qMdpBPadIG-1YwgkrcSqz_FFU130_provenance.